+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Indication and efficacy of fluconazole in oral candidosis



Indication and efficacy of fluconazole in oral candidosis



Mycoses 37(Suppl. 1): 105-109



From 1991 until 1993 we used fluconazole in 56 cases of oral candidosis which could not be managed by local therapy only. In seven cases there was no clinical improvement. A mycological cure was seen in 44 cases. In cases of oral candidosis which do not respond to local therapy fluconazole has proven a success especially in the follow up of patients with oral cancer and in cases of oral precancerous lesions with mycotic colonization.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 002637701

Download citation: RISBibTeXText


Related references

Efficacy, safety and toleration of fluconazole suppositories in the treatment of oral candidosis. Mycoses 42(4): 269-272, 1999

Vulvo vaginal candidosis in african women efficacy and safety of a single oral dose of fluconazole. Current Therapeutic Research 46(4): 768-773, 1989

Efficacy and safety of oral fluconazole in the treatment of patients with tinea corporis, cruris or pedis or cutaneous candidosis : a multicentre, open, noncomparative study. Clinical Drug Investigation 12(2): 59-66, 1996

Relative growth measurement of Candida species in a single concentration of fluconazole predicts the clinical response to fluconazole in HIV infected patients with oral candidosis. Journal of Antimicrobial ChemoTherapy 37(2): 275-283, 1996

Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV-related fluconazole-resistant and fluconazole-susceptible oral candidosis. Aids 11(2): 163-168, 1997

A comparison of the efficacy of oral fluconazole, 150 mg/week versus 50 mg/day, in the treatment of tinea corporis, tinea cruris, tinea pedis, and cutaneous candidosis. International Journal of Dermatology 37(9): 703-705, 1998

Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients. Journal de Mycologie Medicale 9(2): 89-96, 1999

Itraconazole oral solution for treatment of fluconazole resistant oral/esophageal candidosis in HIV-infected patients: Results of a prospective multicenter study. Journal de Mycologie Medicale 9(2): 83-87, 1999

Fluconazole versus nystatin in the treatment of oral candidosis. Acta Odontologica Scandinavica 56(4): 202-205, 1998

Fluconazole-resistant oral candidosis in HIV-infected patients. Aids 9(7): 809-810, 1995

High dose oral fluconazole for oropharyngeal candidosis in AIDS. Journal of Antimicrobial ChemoTherapy 25(4): 720-721, 1990

Fluconazole in the treatment and prophylaxis of oral candidosis in HIV-infected patients. Journal of Drug Development 5(4): 235-249, 1993

Single-dose oral fluconazole in the treatment of vaginal candidosis. Annals of the New York Academy of Sciences 544: 561-563, 1988

Treatment of fluconazole resistant oral candidosis with D0870 in patients with AIDS. Abstracts of the Interscience Conference on Antimicrobial Agents and Chemotherapy 34: 248, 1994

Fluconazole versus ketoconazole in the treatment of oral candidosis in HIV positive subjects. Giornale di Malattie Infettive e Parassitarie 43(10): 914-917, 1991